These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19664159)

  • 1. A fatal case of phlegmonous colitis in chronic hepatitis C receiving combination interferon and ribavirin therapy.
    Pang SH; de Silva K; Napoli J; Jones BE
    Intern Med J; 2009 Jul; 39(7):481-4. PubMed ID: 19664159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
    Abdelmalek MF; Liu C; Valentine JF
    Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C.
    Muhammad N; Jan MA; Rahman N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):651-3. PubMed ID: 15530272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The adherence in the treatment of chronic hepatitis C].
    Pawłowska M; Halota W
    Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
    Iino S
    Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study.
    Posthouwer D; Yee TT; Makris M; Fischer K; Griffioen A; Van Veen JJ; Mauser-Bunschoten EP
    J Thromb Haemost; 2007 Aug; 5(8):1624-9. PubMed ID: 17663735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for combination interferon-ribavirin therapy in chronic hepatitis C].
    Blum HE
    Internist (Berl); 1998 Sep; 39(9):981. PubMed ID: 9788122
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience.
    Tanioka D; Iwasaki Y; Araki Y; Osawa T; Ikeda H; Ando M; Kobashi H; Sakaguchi K; Shiratori Y; Yamamoto K
    Liver Int; 2009 May; 29(5):721-9. PubMed ID: 19141025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair repigmentation in a hepatitis C patient treated with interferon and ribavirin.
    Kavak A; Akcan Y; Korkmaz U
    Dermatology; 2005; 211(2):171-2. PubMed ID: 16088172
    [No Abstract]   [Full Text] [Related]  

  • 15. Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review.
    Kawaguchi T; Ide T; Itou M; Suetsugu M; Yoshioka S; Sakata M; Taniguchi E; Oriishi T; Sumie S; Tsuruta O; Sata M
    J Viral Hepat; 2012 Feb; 19(2):e220-4. PubMed ID: 22239522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of tolerance and efficacy of the treatment of chronic viral hepatitis C in homozygous sickle cell patients].
    El Agheb MO; Grange JD
    Pan Afr Med J; 2015; 20():99. PubMed ID: 26213600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Higher dose of interferon treatment of chronic hepatitis C patient with primary non-response: a case report].
    Liu YL; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):950. PubMed ID: 21205489
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report].
    Rao HY; Ma H; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):631. PubMed ID: 20825725
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection.
    Kim JH; Jang JW; You CR; You SY; Jung MK; Jung JH
    Gut Liver; 2009 Sep; 3(3):218-21. PubMed ID: 20431750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phlegmonous colitis: another source of sepsis in cirrhotic patients?
    Holzer T; Gervaz P; Spahr L; McKee T; Bucher P; Morel P
    BMC Gastroenterol; 2009 Dec; 9():94. PubMed ID: 20003486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.